For immediate release |
9 February 2012 |
Futura Medical plc
("Futura" or "the Company")
|
|||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
FUTURA MEDICAL |
||
2. Reason for the notification (please tick the appropriate box or boxes) |
|
||
An acquisition or disposal of voting rights |
X |
||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||
An event changing the breakdown of voting rights |
|
||
Other (please specify): ___________ |
|
||
3. Full name of person(s) subject to the notification obligation: |
Ignis Investment Services Limited |
||
4. Full name of shareholder(s) (if different from 3.): |
|
||
5. Date of the transaction and date on which the threshold is crossed or reached if different: |
07/02/2012 |
||
|
6. Date on which issuer notified: |
08/02/2012 |
7. Threshold(s) that is/are crossed or reached: |
3% |
8.Notified details: Nominee holdings |
|||||||
A: Voting rights attached to shares |
|||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
3327847 |
|
|
|
|
2,280,800 |
|
3.09% |
B: Financial Instruments |
|
|||||||||
Resulting situation after the triggering transaction |
|
|||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|
|||||
|
|
|
|
|
|
|||||
|
||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||
Resulting situation after the triggering transaction |
||||||||||
Type of financial instrument |
Exercise price |
Expiration Date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|||||
|
|
|
|
|
Nominal |
Delta |
||||
|
|
|||||||||
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
2,280,800.00 |
3.09% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
Vidacos Nominees Ltd (2,280,800.00 3.09%)
Phoenix Group Holdings Impala Holdings Limited Ignis Asset management Ltd Ignis Investment Services Ltd (indirect) |
Proxy Voting: |
|
10. Name of the proxy holder: |
|
11. Number of voting rights proxy holder will cease to hold: |
|
12. Date on which proxy holder will cease to hold voting rights: |
|
13. Additional information: |
Percentage calculation based on Issued Share Capital of 73714112 |
14. Contact name: |
Stuart Caldwell |
15. Contact telephone number: |
0141 222 8158 |